Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rasmus L Marvig

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
Lineages and adapted phenotypes of Pseudomonas aeruginosa persist during elexacaftor/tezacaftor/ivacaftor therapyMaria Pals Bendixen, Oihane Irazoki, Rasmus L Marvig, et al.
Journal of Human Genetics|December 25, 2019
Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathyChrysoula Dimopoulou, Jens D Lundgren, Jon Sundal, et al.
BMC Genomics|August 11, 2016
Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways?Lea M Sommer, Rasmus L Marvig, Adela Luján, et al.
FEMS Microbiology Letters|January 31, 2025
Pseudomonas aeruginosa maintains an inducible array of novel and diverse prophages over lengthy persistence in cystic fibrosis lungsIfigeneia Kyrkou, Jennifer Bartell, Ana Lechuga, et al.
Msystems|June 29, 2021
Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic FibrosisS M Hossein Khademi, Migle Gabrielaite, Magnus Paulsson, et al.
The European Respiratory Journal|October 23, 2020
Omics-based tracking of <i>Pseudomonas aeruginosa</i> persistence in "eradicated" cystic fibrosis patientsJennifer A Bartell, Lea M Sommer, Rasmus L Marvig, et al.
Nature Communications|October 4, 2016
The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactionsNicholas Jochumsen, Rasmus L Marvig, Søren Damkiær, et al.
International Journal of Medical Microbiology : IJMM|June 15, 2016
Substantial molecular evolution and mutation rates in prolonged latent Mycobacterium tuberculosis infection in humansTroels Lillebaek, Anders Norman, Erik Michael Rasmussen, et al.
International Journal of Antimicrobial Agents|November 25, 2015
Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosaMartin Vestergaard, Wilhelm Paulander, Rasmus L Marvig, et al.
Journal of Clinical Microbiology|January 21, 2021
Transmission and Antibiotic Resistance of <i>Achromobacter</i> in Cystic FibrosisMigle Gabrielaite, Jennifer A Bartell, Niels Nørskov-Lauritsen, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
Lineages and adapted phenotypes of Pseudomonas aeruginosa persist during elexacaftor/tezacaftor/ivacaftor therapyMaria Pals Bendixen, Oihane Irazoki, Rasmus L Marvig, et al.
Journal of Human Genetics|December 25, 2019
Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathyChrysoula Dimopoulou, Jens D Lundgren, Jon Sundal, et al.
BMC Genomics|August 11, 2016
Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways?Lea M Sommer, Rasmus L Marvig, Adela Luján, et al.
FEMS Microbiology Letters|January 31, 2025
Pseudomonas aeruginosa maintains an inducible array of novel and diverse prophages over lengthy persistence in cystic fibrosis lungsIfigeneia Kyrkou, Jennifer Bartell, Ana Lechuga, et al.
Msystems|June 29, 2021
Genomic and Phenotypic Evolution of Achromobacter xylosoxidans during Chronic Airway Infections of Patients with Cystic FibrosisS M Hossein Khademi, Migle Gabrielaite, Magnus Paulsson, et al.
The European Respiratory Journal|October 23, 2020
Omics-based tracking of <i>Pseudomonas aeruginosa</i> persistence in "eradicated" cystic fibrosis patientsJennifer A Bartell, Lea M Sommer, Rasmus L Marvig, et al.
Nature Communications|October 4, 2016
The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactionsNicholas Jochumsen, Rasmus L Marvig, Søren Damkiær, et al.
International Journal of Medical Microbiology : IJMM|June 15, 2016
Substantial molecular evolution and mutation rates in prolonged latent Mycobacterium tuberculosis infection in humansTroels Lillebaek, Anders Norman, Erik Michael Rasmussen, et al.
International Journal of Antimicrobial Agents|November 25, 2015
Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosaMartin Vestergaard, Wilhelm Paulander, Rasmus L Marvig, et al.
Journal of Clinical Microbiology|January 21, 2021
Transmission and Antibiotic Resistance of <i>Achromobacter</i> in Cystic FibrosisMigle Gabrielaite, Jennifer A Bartell, Niels Nørskov-Lauritsen, et al.
Pageof 6